Pcn379 - Quantitative Comparison of the Influence of Open Label Trial Design on Patient Reported Outcome Responses – A Metastatic Melanoma Case Study.

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.461
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors

PLoS ONE
Multidisciplinary
2015English

Usability of a Novel Disposable Autoinjector Device for Ixekizumab: Results From a Qualitative Study and an Open-Label Clinical Trial, Including Patient-Reported Experience

Medical Devices: Evidence and Research
MedicineBiomedical Engineering
2016English

Patient Safety in Drug Label Design: Analysis of Reported Adverse Events Before and After Introducing a New Label Design

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2013English

Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2019English

Multiplex Quantitative Analysis of Cancer-Associated Fibroblasts and Immunotherapy Outcome in Metastatic Melanoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Patient-Reported Outcome Measures: The Accuracy of Patient-Reported Revision Spinal Surgery

Orthopedic Research & Physiotherapy
2019English

Metastatic Melanoma of the Tongue: A Rare Case

Actas Dermo-Sifiliograficas
DermatologyForensic MedicinePathologyHistology
2012English

Patient-Reported Outcome Measurement

Journal of the Royal Society of Medicine
Medicine
2010English

Patient Reported Outcome of Celiac Disease

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy